Agave (Agave spp.) and its Traditional Products as a Source of Bioactive Compounds
Agave has been used as a raw material for food and folklore medicinal purposes. Traditional processing involves the use of agave as a source of carbohydrate-rich syrups for direct use or as substrate to yield hydrolyzed fermented products and spirits. Agave plants can accumulate significant amounts of inulin, important molecule with prebiotic activity. The agave plant has been used to feed ruminants in arid areas where drought episodes are prevalent. This plant is an important source of saponins, considered as antinutritional factors but also as anticancer, antifungal, and antiinflammatory agents. Considering the low hydrosolubility of saponins, these compounds are not being recovered from the plant and alternative processes need to be devised. Agave also contains polyphenols with activities such as: anticancer, antioxidant, antidiabetic, anti-inflammatory, antiparasitical, antimicrobial, prebiotics and coadjuvant in mineral absorption. The full phytochemical characterization of the sap, leaves and byproducts generated from the traditional food uses is needed to validate the beneficial effects of agave consumption and its potential use as a source of functional ingredients.
No Supplementary Data
No Article Media
Document Type: Research Article
Publication date: 01 September 2012
More about this publication?
- The journal aims to provide updates to researchers about new bioactive compounds with proven activities in various biological screenings and pharmacological models. The journal will contain information about the structures, biological activities and sources of chemical entities discovered or designed by researchers and published in leading journals. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia.
The journal should prove to be essential reading for pharmacologists, pharmaceutical chemists and medicinal chemists who wish to be kept informed and up-to-date with the latest and most important developments about new bioactive compounds of natural or synthetic origin, including recent patents.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites